Use of tocilizumab for rheumatoid arthritis: new evidence

QR Code

Use of tocilizumab for rheumatoid arthritis: new evidence

Saved in:

Bibliographic Details
Main Author:	Evgeny Lvovich Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2011-12-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

The Role of Tocilizumab in the Treatment of Rheumatoid Arthritis
by: Hirabayashi, Yasuhiko
Published: (2012)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

New aspects of pharmacotherapy for rheumatoid arthritis: small molecule inhibitors
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-04-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

FUNCTIONAL ABILITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOCILIZUMAB THERAPY
by: Anna Sergeyevna Starkova, et al.
Published: (2014-02-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
by: Evgeni Lvovich Nasonov
Published: (2009-12-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-06-01)

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-12-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

EVALUATION OF THE EFFICIENCY OF TOCILIZUMAB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ULTRASOUND AND X-RAY DATA
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-02-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)

Combination therapy for rheumatoid arthritis with rituximab and leflunomide(preliminary results of the Russian ARBITR Registry)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)

Experience of Using Tocilizumab in a Patient with Polyarticular Juvenile Rheumatoid Arthritis with Cervical Spine Lesions
by: E. A. Ligostaeva, et al.
Published: (2015-11-01)

Use of genetically engineered biological agents for the treatment of rheumatoid arthritis: general characteristics (a lecture)
by: Evgeni Lvovich Nasonov, et al.
Published: (2013-04-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE
by: D. A. Kusevich, et al.
Published: (2017-09-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: NEW STRATEGY, NEW TARGETS
by: E. L. Nasonov
Published: (2017-09-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

EULAR RECOMMENDATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS – 2013: GENERAL CHARACTERISTICS AND DISPUTABLE PROBLEMS
by: Evgenii Lvovich Nasonov, et al.
Published: (2014-02-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol’skaja, et al.
Published: (2015-11-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

ABATACEPT FOR RHEUMATOID ARTHRITIS: A NOVEL FORMULATION, NEW MECHANISMS, NEW POSSIBILITIES
by: E. L. Nasonov
Published: (2015-10-01)

Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis
by: Y. M. Spivakovskiy, et al.
Published: (2016-02-01)

CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: O. L. Lomakina, et al.
Published: (2014-01-01)

EXPERIENCE OF USING DRUG TOCILIZUMAB IN A BOY WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2013-11-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)